Quality assessment of platelet rich plasma during anti-platelet therapy

Perfusion

Volumn 22, Issue 1, 2007, Pages 41-50

  Smith, Chad W ^a,b   Binford, Robert S ^a   Holt, David W ^b   Webb, David P ^c  

^a CENTENNIAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aspirin; PDGF bb; Platelet rich plasma; Plavix; TGF b1

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; HEART SURGERY; HUMAN; MONOTHERAPY; PILOT STUDY; PREOPERATIVE CARE; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SURGICAL WOUND; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; WOUND HEALING;

AGED; ASPIRIN; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET FUNCTION TESTS; PLATELET TRANSFUSION; QUALITY ASSURANCE, HEALTH CARE; SURGICAL PROCEDURES, OPERATIVE; TICLOPIDINE; WOUND HEALING;

EID: 34347392319     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659107077950     Document Type: Article

References (32)

1. Kevy SK, Jacobson MS. Comparison of methods for point of care preparation of autologous gel. JECT 2004; 36: 28-35.
2. Aminian B, Shams M, Karim-Aghaee B, Soveyd M, Omrani GR. The role of the autologous platelet-derived growth factor in the management of decubitus ulcer. Acad Medicine Science 1999; 2 (2).
3. Carlson E, Roach RB. Platelet rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol. 1998; 85: 638-46.
4. Lowery G, Kulkarni S, Pennisi AE. Use of autologous growth factors in lumbar spine fusion. Bone 1999; 25: 47-50.
5. Adler SC, Kent KJ. Enhancing wound healing with growth factors. Facial Plastic Surgery Clinical North America 2002; 10: 129-46.
6. Sethi PM, Miranda J, Grauer JN, Friedlaender G, Kadiyala S, Patel T. The use of platelet concentrate in posterolateral fusion: biochemical and histological analysis. Presented at the 28th Meeting of the International Society for the Study of Lumbar Spine, Edinburgh, Scotland, June 2001.
7. Carter CA, Jolly DG, Worden CE Snr., Hendren DG, Kaneb CJM. Platelet rich plasma gel promotes differentiation and regeneration during equine wound healing. Experimental and Molecular Pathology 2003; 74: 244-55.
8. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dentistry 2004; 10 (4): 225-28.
9. Stammers AH, Trowbridge CC, Murdock JD et al. Establishment of a quality control program for platelet gel preparation: a comparison of four commercial devices. Presented at the Society of Cardiovascular Anesthesiologist Meeting: 9th Annual Update on Cardiopulmonary Bypass March 14-19, 2004, Snowmass, CO.
10. Cody C, Trowbridge CC. Application of platelet gel in cardiac surgery: effects on sternal infection. Presented at the Society of Cardiovascular Anesthesiologist Meeting: 9th Annual Update on Cardiopulmonary Bypass March 14-19, 2004, Snowmass, CO.
11. Despotis G, Goodnough LT. Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. Ann Thorac Surg 2000; 70: s20-32.
12. Doukas J, Chandler LA, Gonzalez AM et al. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Human Gene Therapy. 2001; 12(7): 738-98.
13. Waters J, Roberts KC. Database review of point of care with platelet gel. JECT 2004; 36: 250-54.
14. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surgery 2004; 62: 489-96.
15. Graff J, Klinkhardt U, Schini-Kerth VB et al. Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor. J Pharmacol Experimental Therapeutics 2002; 300: 952-57.
16. Glee PF, Mustoe TA, Lingelbach J et al. Platelet-derived growth factor and transforming growth factor-b enhance tissue repair activities by unique mechanisms. J Cell Biol 1989; 109: 429-40.
17. Haynesworth SE, Kadiyala S, Liang L, Thomas T. Mitogenic stimulation of human mesenchymal stem cell by platelet release suggest a mechanism for enhancement of bone repair by platelet concentrates. Presented at the 48th Meeting of the Orthopedic Research Society, Boston, MA, 2002.
18. Sanchez AR, Sheridan PJ, Kupp LI. Is platelet rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003; 18:93-103.
19. Zhao LL, Davidson JD, Wee SC, Roth SI, Mustoe TA. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Archives of Surgery 1994; 129 (10): 1043-9.
20. Vesaluoma M, Teppo A-M, Gronhagen-Riska C, Tervo TM. Platelet derived growth factor - BB in tear fluid: a potential modulator of corneal wound healing following photorefractive keratectomy. Current Eye Research 1997; 16:825-31.
21. Reuterdahl C, Sundberg C, Rubin K, Funa K, Gerdinl B. Tissue localization of b receptors for platelet-derived growth factor and platelet-derived factor B chain during wound repair in humans. J Clin Investig 1993; 91: 2065-75.
22. Eppley B, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet rich plasma: implication for wound healing. Plastic and Reconstructive Surgery 2004; 14 (6): 1502-08.
23. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JE. Effectiveness of platelet releasant for treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001; 24: 483-88.
24. Van der Planken M, Claeys MJ, Vertessen FJ et al. Comparison of turbidimetric aggregation and in vitro bleeding time for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation. Thrombosis Research 2003; 111: 159-64.
25. Thomson MICROMEDEX v123., Aspirin 1974-2004.
26. Thomson MICROMEDEX v123., Clopidogrel 1974-2004.
27. Serebruary VL, Alford AB, Meister AF et al. Clinical utility of PFA for the assessment of the platelet status in patients with congestive heart failure. Thrombosis Research 2001; 101: 427-33.
28. Salat A, Kroess S, Felfernig-Boehm D, Felfernig M et al. Comparison of in vitro closure time with whole blood electrical aggregometry and platelet surface Antigen expression in healthy volunteers. Thrombosis Research 2002; 105: 205-8.
29. von Pape KW, Aland E, Bohner J. Platelet function analysis with PFA-100 in patients medicated with acetylsalicylic acid strongly depends on concentration of sodium citrate used for anticoagulation of blood sample. Thrombosis Research 2000; 98: 295-99.
30. Osende J, Fuster V, Lev EI et al. Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests. Circulation 2001; 103: 1488-91.
31. Escudero C, Santos M, Buj'an J et al. Optical aggreometry versus the PFA-100: experimental studies in pigs treated with propofol. Platelets 2001; 12: 133-37.
32. Gope R. Effect of epidermial growth factor and platelet derived growth factors on wound healing process. Indian J Med Res 2002 Nov; 116: 201-6.